3BBLACKBIO vs CORONA: Stock Comparison

3B Blackbio DX Ltd vs Corona Remedies Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Corona Remedies Ltd is the larger company by market capitalisation. 3B Blackbio DX Ltd shows a lower P/E, lower leverage and a higher net margin, while Corona Remedies Ltd shows a higher ROE, a higher dividend yield and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of 3B Blackbio DX Ltd and Corona Remedies Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, 3BBLACKBIO is more favourable on 7 of 13 scored metrics and CORONA on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap

CORONA is the larger company

₹12,654 Cr vs ₹1,098 Cr

P/E Ratio

3BBLACKBIO has a lower P/E

19x vs 69.44x

P/B Ratio

3BBLACKBIO has a lower P/B

3.43x vs 17.21x

EPS

3BBLACKBIO has higher earnings per share

₹68.3 vs ₹30.3

Dividend Yield

CORONA has a higher dividend yield

0.49% vs 0.34%

Qtr Sales Growth

3BBLACKBIO has stronger quarterly sales growth

57.5% vs 20.2%

Qtr Profit Growth

CORONA has stronger quarterly profit growth

43.7% vs 13.8%

ROE

CORONA has a higher ROE

29.5% vs 19.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

Metric	3BBLACKBIO	CORONA
Live Price	₹1,298.8	₹2,069.7
Day Change	0.5%	-1.36%
Volume	10,694	23,031
52-Week High	₹1,441.5	₹2,140
52-Week Low	₹1,085	₹1,336.6
Distance from 52W High	-9.9%	-3.29%

Valuation

Metric	3BBLACKBIO	CORONA
Market Cap	₹1,098 Cr	₹12,654 Cr
P/E Ratio	19x	69.44x
P/B Ratio	3.43x	17.21x
EPS	₹68.3	₹30.3
Book Value	₹378	₹122
Dividend Yield	0.34%	0.49%

Growth

Metric	3BBLACKBIO	CORONA
Revenue Growth (TTM YoY)	0%	0%
EPS Growth (TTM YoY)	0%	0%
Qtr Sales Growth	57.5%	20.2%
Qtr Profit Growth	13.8%	43.7%

Profitability & Leverage

Metric	3BBLACKBIO	CORONA
ROE	19.8%	29.5%
ROCE	25.5%	33.3%
Net Margin	42.23%	13.19%
Operating Margin	40%	21%
Debt to Equity	0.01x	0.22x

Shareholding

As of Mar 2026 • change vs previous quarter

Metric	3BBLACKBIO	CORONA
Promoter Holding	38.46%	69%
FII Holding	2.57%	3.63%▲ 1.38 pp
DII Holding	1.98%▲ 0.1 pp	12.9%▲ 5.88 pp
Public Holding	54.51%▲ 0.23 pp	14.48%▼ 7.26 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: 3B Blackbio DX Ltd and Corona Remedies Ltd.

Related Comparisons

Infosys vs TCS HDFC Bank vs ICICI Bank Axis Bank vs Kotak Mahindra Bank HCL Technologies vs Wipro Hindustan Unilever vs ITC Maruti Suzuki vs Tata Motors

Browse all stock comparisons →

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.